Ligand Pharmaceuticals Incorporated
P/E (Price-to-Earnings)
Price
EPS
P/E (Price-to-Earnings)
| Fiscal Year | P/E (Price-to-Earnings) | EPS | Price |
|---|---|---|---|
| Dec 2011 | 14.81x | $0.50 | $7.40 |
| Sep 2012 | 80.86x | $0.16 | $12.94 |
| Dec 2013 | 59.66x | $0.55 | $32.81 |
| Dec 2014 | 58.24x | $0.57 | $33.19 |
| Dec 2015 | 6.31x | $10.72 | $67.64 |
| Dec 2016 | 316.94x | $0.20 | $63.39 |
| Dec 2017 | 15.25x | $5.60 | $85.42 |
| Dec 2018 | 15.12x | $5.60 | $84.65 |
| Dec 2019 | 2.22x | $29.34 | $65.06 |
| Dec 2021 | 27.93x | $3.45 | $96.36 |
| Mar 2022 | 44.83x | $1.49 | $66.80 |
| Dec 2023 | 24.29x | $2.94 | $71.42 |
| Sep 2024 | 42.02x | $2.55 | $107.15 |
| Dec 2025 | 31.03x | $6.13 | $190.20 |